FibroGen Inc
Change company Symbol lookup
Select an option...
FGEN FibroGen Inc
OMC Omnicom Group Inc
CHDN Churchill Downs Inc
SGTB Kuboo Inc
BBBMX BBH Limited Duration Fund Class N
VICI VICI Properties Inc
DDS Dillard's Inc
ALIN-E Altera Infrastructure LP
AUVGF Australian Vintage Ltd
LQSIF Alcanna Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing and commercializing a pipeline of first-in-class therapeutics. The Company applies its capabilities in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance innovative medicines for the treatment of unmet needs. The Company is currently developing and commercializing roxadustat, an oral small molecule inhibitor of HIF prolyl hydroxylase activity, for anemia associated with chronic kidney disease (CKD). Roxadustat is also in clinical development for anemia associated with myelodysplastic syndromes (MDS) and for chemotherapy-induced anemia (CIA). Pamrevlumab, an anti-CTGF human monoclonal antibody, is in clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), locally advanced unresectable pancreatic cancer (LAPC), Duchenne muscular dystrophy (DMD), and coronavirus (COVID-19).

Closing Price
$20.23
Day's Change
-0.41 (-1.99%)
Bid
--
Ask
--
B/A Size
--
Day's High
21.22
Day's Low
20.10
Volume
(Light)
Volume:
686,958

10-day average volume:
871,255
686,958
  • Prev Close
    20.64
  • Today's Open
    20.80
  • Day's Range
    20.10-21.22
  • Avg Vol (10-day)
    871.3K
  • Last (time)
    4:00p ET 05/07/21
  • Last (size)
    400
  • 52-Wk Range
    18.12 - 57.21
    LowHigh
  • (02/12/21 - 04/09/21)
    11.64%
  • 80.8%
  • Market Cap
    1.9B
  • Shares Outstanding
    92.1M
  • -2.13
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.0
  • 77.55
  • (% of float 04/15/21)
    9.83

Latest News

May 08, 2021
1:54 pm ET
Accesswire
1:15 pm ET
Globe Newswire
8:07 am ET
Newsfile
May 07, 2021
7:05 pm ET
Globe Newswire
6:47 pm ET
Newsfile
6:06 pm ET
Accesswire
5:02 pm ET
Newsfile
4:30 pm ET
Accesswire
3:15 pm ET
Accesswire
12:25 pm ET
Accesswire
10:16 am ET
Accesswire
9:30 am ET
Accesswire
5:40 am ET
Accesswire
May 06, 2021
10:50 pm ET
Newsfile
9:31 pm ET
PR Newswire
7:21 pm ET
Accesswire
4:50 pm ET
Accesswire
11:29 am ET
Accesswire
11:07 am ET
Newsfile
10:51 am ET
Newsfile
9:31 am ET
Accesswire
8:52 am ET
Globe Newswire
6:33 am ET
Newsfile
May 05, 2021
7:17 pm ET
Newsfile
6:19 pm ET
Newsfile
5:17 pm ET
Newsfile
3:30 pm ET
Newsfile
1:46 pm ET
Accesswire
1:40 pm ET
PR Newswire
1:24 pm ET
Newsfile
11:55 am ET
Newsfile
11:30 am ET
PR Newswire
11:16 am ET
Accesswire
10:40 am ET
Newsfile
6:10 am ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.